News

Jim Mellon-backed cancer drug company SalvaRx launches on Aim

Jim Mellon-backed cancer drug company SalvaRx launches on Aim
Failed Polish oil and gas investor 3Legs will relaunch on the junior market as a cancer drug company backed by multi-millionaire investor Jim Mellon. Failed Polish oil and gas investor 3Legs will relaunch on the junior market as a cancer drug company backed by multi-millionaire investor Jim Mellon. In the face of collapsing commodity prices the shale business has undergone a complete transformation after it announced an £8.8m reverse takeover of cancer immunotherapy development company SalvaRx. Shares will start trading on Tuesday at 35p with a £1.95m share placing also take place.